Company
United StatesUCARM Stapleton Clinic, Denver, CO – FDA Inspections
Inspection records and compliance data for UCARM Stapleton Clinic in Denver, Colorado. 3 FDA inspections on record, last inspected February 26, 2020.
Company Profile
This profile covers UCARM Stapleton Clinic based in Denver, Colorado, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected March 3, 2014. Last inspected February 26, 2020.
Most cited issue areas
- Review and approval of procedures1 inspection
- SOP for release; reactive for CMV1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 26, 2020 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1122658 |
| January 10, 2017 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 998147 |
| March 3, 2014 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 868586 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
UCARM Stapleton Clinic
FEI Number
3010267012
Address
3055 Roslyn St Unit 230, Denver, Colorado 80238, United States
Country
United States
ID: cd6acb42-047a-4843-a652-7e262503ff70